Overview and Clinical Importance
Domain 4 (Medicine) is the LARGEST domain on the BCSE, comprising nearly 25% of all exam questions (50-55 questions). This guide covers four critical body system categories that frequently appear on the examination: endocrine diseases, neurological disorders, musculoskeletal conditions, and dermatological diseases. These topics require integration of pathophysiology, clinical recognition, diagnostic approaches, and therapeutic management across multiple species.
High-YieldMedicine questions test your ability to integrate basic science knowledge with clinical application. Focus on etiology, pathophysiology, clinical signs, diagnosis, and treatment protocols across ALL species.
| Feature |
Canine DM |
Feline DM |
| Primary Type |
Type 1-like (insulin-dependent) - immune-mediated beta cell destruction |
Type 2-like (insulin resistance) - amyloid deposition, beta cell exhaustion |
| Risk Factors |
Genetics, pancreatitis, immune-mediated disease, obesity |
Obesity (number one risk), physical inactivity, certain breeds (Burmese), age greater than 6 years |
| Sex Predisposition |
Unspayed females (2x risk due to progesterone-induced insulin resistance) |
Male cats (1.5-2x more common) |
| Remission Potential |
Rare - most dogs are permanently insulin-dependent |
25-50% can achieve remission with early, aggressive treatment |
| Concurrent Disease |
Hypothyroidism, hyperadrenocorticism, pancreatitis |
Hypersomatotropism (acromegaly) causes 25% of feline DM cases in UK studies |
| Preferred Insulin |
Porcine lente (Vetsulin), NPH insulin |
Glargine (Lantus) or PZI - longer duration preferred |
| Diagnostic Test |
Interpretation |
| Blood Glucose |
Persistent hyperglycemia greater than 200 mg/dL (dogs) or greater than 250-300 mg/dL (cats - higher due to stress hyperglycemia) |
| Fructosamine |
Reflects average glucose over 2-3 weeks. Elevated values greater than 400 umol/L confirm persistent hyperglycemia. Not affected by stress. |
| Urinalysis |
Glucosuria (renal threshold: dogs approximately 180 mg/dL, cats approximately 280 mg/dL). Check for concurrent UTI. |
| Serum Chemistry |
Hypercholesterolemia, hypertriglyceridemia, elevated ALT/ALP. Rule out concurrent diseases. |
| Clinical Feature |
Details |
| Signalment |
Cats greater than 8 years old. No breed predisposition (Siamese and Himalayan may have decreased risk) |
| Physical Exam |
Palpable thyroid nodule (90%), tachycardia, weight loss, unkempt coat, hyperactivity, muscle wasting |
| Cardiovascular |
Systemic hypertension (15-20%), tachyarrhythmias, gallop rhythm, hypertrophic cardiomyopathy-like changes |
| Renal Masking |
CRITICAL: Hyperthyroidism increases GFR and can MASK underlying chronic kidney disease. Always reassess renal function after treating hyperthyroidism. |
| Treatment |
Advantages |
Disadvantages |
| Methimazole (medical) |
Reversible, relatively inexpensive, allows assessment of renal function during trial |
Lifelong therapy, GI side effects, potential hepatotoxicity, rare blood dyscrasias, requires monitoring |
| Radioactive Iodine (I-131) |
Curative in 95% with single treatment, no anesthesia, treats ectopic tissue, gold standard |
Expensive, requires specialized facility, radiation safety protocols, irreversible |
| Surgical Thyroidectomy |
Curative, immediate effect, allows histopathology |
Anesthesia risk in older cats, hypocalcemia risk (parathyroid damage), recurrence if ectopic tissue |
| Iodine-restricted diet (y/d) |
Non-invasive, no medication |
Strict compliance required (sole diet), may not control all cases, expensive |
| Clinical Feature |
Details |
| Predisposed Breeds |
Golden Retriever, Doberman Pinscher, Irish Setter, Dachshund, Cocker Spaniel, Boxer, Great Dane |
| Metabolic Signs |
Weight gain without polyphagia, lethargy, mental dullness, cold intolerance, exercise intolerance |
| Dermatologic Signs |
Bilateral symmetric non-pruritic alopecia, "rat tail," hyperpigmentation, seborrhea, recurrent pyoderma, myxedema |
| Cardiovascular |
Bradycardia, weak apex beat, decreased contractility |
| Neuromuscular (rare) |
Peripheral neuropathy, facial nerve paralysis, vestibular signs, megaesophagus, laryngeal paralysis |
| Test |
Interpretation |
| Total T4 |
Low T4 is sensitive but NOT specific. Many factors decrease T4 (illness, drugs like glucocorticoids, sulfonamides, phenobarbital). Normal T4 essentially rules OUT hypothyroidism. |
| Free T4 (fT4ed) |
More accurate than total T4, less affected by non-thyroidal illness. Free T4 by equilibrium dialysis (fT4ed) is preferred - avoid analog methods. |
| TSH |
Elevated TSH with low T4/fT4 strongly supports primary hypothyroidism. However, 25-40% of hypothyroid dogs have NORMAL TSH due to pituitary exhaustion or assay limitations. |
| Thyroglobulin Autoantibodies |
Positive in lymphocytic thyroiditis. Indicates immune-mediated disease but not necessarily current hypothyroid state. |
| Secondary Findings |
Fasting hypercholesterolemia, mild non-regenerative anemia (normocytic, normochromic), elevated CK |
Section 1: Endocrine Diseases
Endocrine diseases are among the most commonly tested topics on the BCSE due to their frequency in clinical practice and the integration of physiology, pathophysiology, and therapeutics required for their management.
Diabetes Mellitus
Diabetes mellitus (DM) is one of the most common endocrine diseases in both dogs and cats, with prevalence estimates ranging from 0.4% to 1.2% depending on the population studied. Understanding the species differences in pathophysiology is CRITICAL for exam success.